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Up to 12000 patients with gynaecological, urological and rectal cancer undergo radical pelvic radiotherapy annually in the UK. More
than 70% develop acute inflammatory changes causing gastrointestinal symptoms during treatment because healthy bowel tissue is
encompassed in the radiation field. In total, 50% go on to develop chronic bowel symptoms, which affect quality of life due to
permanent changes in the small and large intestine. Nutritional intervention may influence acute and chronic bowel symptoms but the
validity of the advice given to patients is not clear. To assess the incidence and significance of malnutrition and to examine the efficacy
of therapeutic nutritional interventions used to manage gastrointestinal side effects in patients undergoing pelvic radiotherapy and
those with chronic bowel side effects after treatment, a critical review of relevant original studies on human subjects was carried out
using a specific set of mesh terms in MEDLINE and EMBASE databases and the Cochrane Library in September 2003. Full texts of all
relevant articles were collected and reference lists were checked. Sources of grey literature including conference abstracts and web-
based information were also reviewed. A total of 36 papers published in peer-reviewed journals between 1966 and 2003 were
identified. In all, 14 randomised controlled trials, 12 prospective cohorts, four retrospective, two qualitative, one validation, one pilot
study and two case reports were obtained. These included 2646 patients. Eight articles including three conference abstracts and web-
based information were found. None of the studies was definitive because of weakness in methodology. No studies could be
combined because the interventions and the end points were different. There is no evidence base for the use of nutritional
interventions to prevent or manage bowel symptoms attributable to radiotherapy. Low-fat diets, probiotic supplementation and
elemental diet merit further investigation.
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A total of 11–12000 patients with gynaecological, urological and
rectal cancer undergo radical pelvic radiotherapy annually in the
UK. This reflects about 20% of patients diagnosed with pelvic
malignancy (Moller et al, 2003). More than 70% develop acute
inflammatory small intestinal changes (Resbeut et al, 1997),
leading to gastrointestinal symptoms during treatment partly
because healthy bowel tissue is encompassed in the radiation field.
Acute symptoms include diarrhoea, abdominal pain, tenesmus
or nausea that usually start during the second or third week of a
course of radical radiotherapy and resolve within a fortnight of
completion of radiotherapy (Ajlouni, 1999). The incidence of
chronic bowel damage is difficult to assess, as patients may be lost
to follow-up, may not report any changes to their clinician or may
not be identified by scoring systems historically used in clinical
trials. In 5–10% of patients, serious gastrointestinal problems may
occur (Ooi et al, 1999; Denton et al, 2000; Nostrant, 2002). These
include bowel obstruction, fistulation, intractable bleeding or
secondary cancers. A further 6–78% of patients develop less severe
symptoms, which nevertheless detrimentally affect quality of life
(Kollmorgen et al, 1994; Potosky et al, 2000; Gami et al, 2003).
These may include urgency, frequency, faecal incontinence,
diarrhoea, steatorrhoea, tenesmus, pain, constipation and
weight loss (Andreyev et al, 2003). The severity of acute bowel
toxicity may predetermine the degree of chronic bowel changes
(Donaldson et al, 1975). Therefore, early intervention to prevent or
reduce acute toxicity may be worthwhile in the long term.
A number of radiotherapy techniques are used to treat cancers
within the pelvis. These may influence the dose that is delivered to
the tumour and surrounding structures. Radiotherapy damages
tissue because energy dissipated from ionising radiation generates
a series of biochemical events inside the cell. Free radicals are
formed and disrupt DNA, preventing replication, transcription and
protein synthesis. When given in combination with chemotherapy,
the risk to normal tissues may be enhanced. The small intestine is
particularly susceptible to damage because its cells are usually
rapidly proliferating, and bile acid and pancreatic enzymes may
potentiate damage to the mucosal glycocalyx (Sullivan, 1962;
Mulholland et al, 1984).
Consideration of nutrition before, during and after radiotherapy
to the pelvis may be important for several reasons. Nutritional risk
describes patients who are likely to develop malnutrition as a
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lresult of their illness, but the prognostic significance of nutritional
risk is not clear. Malnutrition per se is an independent adverse
prognostic factor in many cancers (Bozzetti, 2001). It may occur
due to physiological, metabolic, psychological or iatrogenic
processes, which exist as a result of malignancy and may affect
morbidity, mortality and response to treatment (Argiles and
Lopez-Soriano, 1999).
Specific therapeutic nutritional intervention before and during
radiotherapy may induce a radio-protective effect for healthy
tissues, for example, elemental diet by various mechanisms
including attenuation of biliary and pancreatic secretions
(McArdle et al, 1974, 1985; Pageau and Bounous, 1977; Mester
et al, 1990) or nutritional intervention may be used for its radio-
enhancing effect on malignant tissues, for example, polyunsatu-
rated fatty acids (Conklin, 2002).
Manipulation of habitual diet after radiotherapy may help to
reduce or eliminate chronic, undesirable changes in bowel habit
once they have occurred. A number of dietetic interventions such
as lactose restriction, fat restriction, reduced intake of motility
stimulants such as caffeine and a decrease in fibre-containing
foods (Classen et al, 1998) have been suggested.
This review has two aims. First, to assess the incidence and
significance of malnutrition in patients undergoing pelvic radio-
therapy and those with chronic bowel side effects resulting from
pelvic radiotherapy and second, to examine the efficacy of
therapeutic nutritional interventions used to manage gastrointest-
inal side effects of pelvic radiotherapy.
METHODS
A search of original literature was carried out using MEDLINE and
EMBASE databases from 1966 to May 2003 and the Cochrane
Library. Animal data were excluded. Search terms included pelvic
radiotherapy, gynaecological cancer, elemental diet, probiotics,
lactose, reduced fat, enteral nutrition, parenteral nutrition,
radiation-induced bowel damage, radiation enteritis, bowel
symptoms and diarrhoea. These terms were used to generate
reference listings, which were then examined against inclusion and
exclusion criteria, and full texts of relevant papers were retrieved.
Reference lists in individual papers were checked to identify other
relevant publications. Grey literature including abstracts of radio-
therapy and nutrition conferences and UK doctoral theses were
searched in order to obtain unpublished work in the area. Finally,
searches using recognised search engines such as ‘Google’,
‘Microsoft Network’ and ‘Ask Jeeves’ were carried out on the
Internet to identify information disseminated to the general public
and health professionals via new media, especially regarding
nonconventional or complementary nutrition support.
Trials were included if they had recruited patients with
gynaecological, rectal or urological malignancy and measured
acute or chronic gastrointestinal toxicity to pelvic radiotherapy,
while intervening with nutrition to alleviate side effects and/or
assessed nutritional status of patients before the start of or during
a course of pelvic radiotherapy.
The primary outcome sought was bowel toxicity as assessed by
the Radiation Therapy Oncology Group scoring tool (Cox et al,
1995) (Table 1) or other surrogate indicators such as stool
frequency and consistency, record of use of antidiarrhoeal
medications or patient-reported gastrointestinal symptoms. Sec-
ondary outcome measures included nutritional status assessed by
change in weight, other anthropometric indicators and changes in
dietary intake.
Randomised controlled trials were assessed for methodological
quality according to the method of randomisation and group
allocation. Studies were graded ‘A’ adequate methodology, ‘B’
inadequate methodology and ‘C’ not stated (The Cochrane Library,
2003). Nonrandomised studies were assessed on methodology and
sampling strategy but could not be assessed for quality using any
validated grading systems.
RESULTS
A total of 2646 patients in 36 papers and eight sources of grey
literature including three conference abstracts and data in non-
peer-reviewed journals or the internet, published between 1966
and 2003, were identified. No systematic reviews, 14 randomised
controlled trials, 12 prospective cohorts, four retrospective, one
validation study, two qualitative, one pilot study and two case
reports were retrieved. No papers have been excluded. The papers
are summarised in Tables 2–5.
Methodological quality of trials
Approximately half of the papers reviewed were of randomised
controlled study design. However, methodology was often weak,
with reporting of method of randomisation, concealment of
allocation and blinding lacking from many papers (Brown et al,
1980; Foster et al, 1980; Kinsella et al, 1981; Moriarty et al, 1981;
Stryker and Bartholomew, 1986; Salminen et al, 1988; Karlson et al,
1989; Bye et al, 1992; Chowdhury et al, 2002; Delia et al, 2002). The
choice of randomisation in papers that reported their methodology
was adequate in two studies (Urbancsek et al, 2001; Martin et al,
2002). Intention-to-treat analyses were described in two papers
(Urbancsek et al, 2001; Martin et al, 2002). It was unclear as to
whether such methods were used in other studies. In view of these
problems, it is difficult to draw clear conclusions regarding
efficacy or effect of the interventions used.
Malnutrition and pelvic radiotherapy
Five papers (one randomised controlled trial (Bye et al, 1992), two
prospective cohort (Hulshof et al, 1987; Pia de la Maza et al, 2001),
one retrospective (Stryker and Velkley, 1980) and one validation
study (Ferguson et al, 1999)) were identified, which assessed the
incidence of nutritional risk in patients undergoing pelvic radio-
therapy (Table 2). No papers were found that examined whether
nutritional status at the start of radiotherapy had any impact on
toxicity or outcomes after radiotherapy or the importance of its
Table 1 RTOG (Radiation Therapy Oncology Group) toxicity criteria
Toxicity Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
Lower GI
including
pelvis
No change Increased frequency or
change in quality of
bowel habits not
requiring medication/
rectal discomfort not
requiring analgesics
Diarrhoea requiring
parasympatholytic
drugs (e.g. Lomotil)/
mucous discharge not
necessitating sanitary
pads/rectal or
abdominal pain
requiring analgesics
Diarrhoea requiring
parenteral support/severe
mucous or blood discharge
necessitating sanitary pads,
abdominal distension (flat
plate radiograph
demonstrated distended
bowel loops)
Acute or subacute obstruction,
fistula or perforation; GI
bleeding requiring transfusion;
abdominal pain or tenesmus
requiring tube decompression
or bowel diversion
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lpresence or absence specifically in patients exposed to irradiation
to the pelvis. None of the papers assessed the impact of acute
diarrhoea on nutritional status, although four of the five identified
diarrhoea as an important side effect of treatment, with incidence
ranging from 6 to 87%.
Two of the studies (including 121 patients) assessed nutritional
risk before starting radiotherapy (Ferguson et al, 1999; Pia de la
Maza et al, 2001). The reported incidence ranged from 11 to 33%.
Data were based on patient reports of decreased appetite and
weight. In total, 5% weight loss before starting treatment was
reported to have occurred in 32% of patients (mean percentage,
intervention and control groups) by the randomised controlled
trial (Bye et al, 1992). The remaining papers (Stryker and Velkley,
1980; Hulshof et al, 1987; Bye et al, 1992) (380 patients) assessed
change in nutritional status during pelvic irradiation. The
incidence of weight loss during treatment varied from 0 to 83%
in these studies.
Nutritional interventions
Dietary modifications during pelvic radiotherapy In total, 18
studies were identified that examined dietary interventions in
adults and children receiving pelvic radiotherapy (Table 3). The
search identified studies comparing a range of nutritional
interventions:
  Low-fat diets with or without additional medium-chain
triglyceride supplementation compared with unrestricted fat
intake or low-fat diets (Karlson et al, 1989; Bye et al, 1992).
  Lactose restriction or modification either uncontrolled (Stryker
and Bartholomew, 1986; Bye et al, 1992) or compared to normal
diet.
  Low residue diet (Liu et al, 1997).
  Probiotic supplementation in sachet or fermented yogurt
presentation and modified food intake compared with modified
food intake alone (Salminen et al, 1988; Delia et al, 2002).
  Elemental diet as a supplement to modified food intake or as a
sole source of nutritional intake compared to modified diet or
total parenteral nutrition (Brown et al, 1980; Foster et al, 1980;
McArdle et al, 1986; Craighead and Young, 1998; Capirci and
Polico, 2000).
  Enteral and parenteral protein-calorie nutrition support
(Valerio et al, 1978; Kinsella et al, 1981; Moriarty et al, 1981;
Macia et al, 1991; McCarthy and Weihofen, 1999; Chowdhury
et al, 2002).
  Enzyme preparation supplement (Martin et al, 2002).
Low-fat dietary regimens, using 20–40g fat per day (Karlson
et al, 1989; Bye et al, 1992), induced a significant reduction in
diarrhoea, the use of diarrhoea rescue medication and frequency of
bowel motions in the 164 patients studied. However, the two
studies introduced additional dietary manipulations and did not
control for these, which included the use of a medium-chain
triglyceride supplement providing 1000kcal (Karlson et al, 1989)
and lactose restriction (Bye et al, 1992), rendering it unclear as to
which intervention had the beneficial effect. Another study focused
on lactose, using a randomised controlled design that only
modified lactose intake (Stryker and Bartholomew, 1986; Bye
et al, 1992). No change in bowel symptoms assessed by the RTOG
tool were measured in this study (Stryker and Bartholomew, 1986).
A retrospective study assessed the efficacy of introducing a
reduced residue regimen in men with prostate cancer undergoing
pelvic radiotherapy. It did not identify statistically significant
changes in radiotherapy-induced toxicity, particularly gastroin-
testinal symptoms (Liu et al, 1997). In total, 17% of the patients
did not comply with the recommended diet.
Two randomised studies, including 214 patients (Salminen et al,
1988; Delia et al, 2002), used probiotics during pelvic radiotherapy
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land demonstrated a decrease in the mean number of bowel
movements (Po0.05) and a decrease in the incidence of diarrhoea
(Po0.01), using VSL #3 sachets three times daily and 2 10
9 daily
dose of a L. acidophilus in a fermented yogurt product, respectively.
In addition, one of the studies (Salminen et al, 1988) also restricted
fibre, fat and obvious sources of lactose in all patients.
Five studies (including 847 patients), of which four were
randomised controlled trials (Brown et al, 1980; Foster et al,
1980; McArdle et al, 1986; Capirci and Polico, 2000) and one was a
phase II pilot study (Craighead and Young, 1998), investigated the
use of elemental diet during pelvic radiotherapy. The type of
elemental diet implemented varied between studies in terms of the
specific product and the relative caloric contribution it provided.
Three studies including a total of 749 patients found a
statistically significant decrease in the incidence and severity of
acute diarrhoeal symptoms (McArdle et al, 1986; Craighead and
Young, 1998; Capirci and Polico, 2000). However, the largest study,
a multicentre 674 patient trial, has been published only as a
conference abstract and a non-peer-reviewed summary booklet.
Two of the studies (Craighead and Young, 1998; Capirci and
Polico, 2000) used elemental diet as a supplement to normal diet,
providing approximately 900kcal per day. The feasibility study
carried out in 17 patients indicated that compliance (deemed as
achieving the target volume of elemental diet for more than 80% of
the time) to the regimen was achieved in 76.5% of the participating
patients. One study (McArdle et al, 1986) used elemental diet as the
sole source of nutrition in tube-fed patients. The authors revised
their methodology and halted randomisation to the parenteral
nutrition arm partway through the study. Instead, retrospective
controls were used for comparison. They reported a significant
perceived benefit in the elementally fed intervention arm. No
objective measures were described. Finally, one study (Brown et al,
1980) used an elemental-supplemented regimen, but failed to show
any significant differences in bowel symptoms. Controls were
asked to follow a low roughage diet, while the treatment group
followed the same low roughage diet supplemented with three
sachets of ‘Vivonex HN elemental feed’ providing 900kcal. More
than 50% of patients could not manage to consume the Vivonex
HN for the whole duration of their radiotherapy.
A study comparing a low-fibre diet (specific content unknown)
in controls, with the same diet alongside elemental supplementa-
tion (Foster et al, 1980), did not assess the effect of this
intervention on gastrointestinal symptoms. Instead, haematologi-
cal parameters and weight were compared. There were no
significant differences in weight loss between groups.
Four randomised controlled trials (including 204 patients)
investigated enteral nutrition support during pelvic radiotherapy
(Moriarty et al, 1981; Macia et al, 1991; McCarthy and Weihofen,
1999; Chowdhury et al, 2002). There is little detailed information
about the clinical effect that this approach had in terms of
treatment toxicity. A range of isocaloric, high protein/calorie
enteral supplements were used in two studies (Moriarty et al, 1981;
McCarthy and Weihofen, 1999) and concluded that the energy and
protein intakes of supplemented groups were improved compared
to controls. No outcome measures such as toxicity from radio-
therapy, tumour control or survival were reported and no
significant changes in biochemical or haematological parameters
were found.
A study using specific dietary advice to remove gluten and
lactose and providing high calorie advice for patients with low
appetites (Macia et al, 1991) showed a significant decrease in Body
Mass Index and Mid-Arm Muscle Circumference in control group
patients, but both groups had similar gastrointestinal toxicity.
Two studies, both randomised (Valerio et al, 1978; Kinsella et al,
1981), evaluated the use of parenteral nutrition vs oral nutrition in
patients undergoing pelvic radiotherapy. Both indicated that the
side effects of treatment and nutritional status were improved in
the parenteral fed arms. A reduction in bulk of tumour by 50% was
reported in 45% of the parenteral nutrition group (Valerio et al,
1978). However, in both studies, group allocation methods meant
Table 3 Dietary modifications during pelvic radiotherapy
Study Study type n Intervention
Bowel toxicity
Intervention Control
Brown (1980) RCT 68 Elemental diet — —
Bye (1992) RCT 143 Low fat; low lactose 1.1 loose stools/week (Po0.01) 1.7 loose stools/week
Capirci (2000) RCT 680 Elemental diet 16% Grade 1 25% Grade 1
12% Grade 2 27% Grade 2
Chowdury (2002) RCT 20 Micronutrient supplement —
Craighead (1998) Phase II feasibility
pilot
17 Elemental diet 5.9 (3.4–8.3) days of diarrhoea
(Po0.05)
12.2 (10.2–14.2) days of diarrhoea
Delia (2002) RCT 190 VSL #3 probiotic 0% Grade 4 21.4% Grade 4
65.3% Grade 2 23.8% Grade 2
Foster (1980) RCT 32 Elemental diet —
Karlson (1989) RCT (conference
abstract)
21 Low-fat diet 1.670.9 bowel movements/day 2.071.0 bowel movements/day
Kinsella (1981) RCT 32 PN —
Liu (1997) Retrospective study 156 Low residue Majority Grade 1
Macia (1991) RCT 93 Protein/calorie
supplementation
——
Martin (2002) Double-blind RCT 56 Enzyme capsule 57% moderate bowel symptoms 36% moderate bowel symptoms
(P¼0.01)
Mcardle (1986) Prospective cohort 56 Elemental diet —
Mccarthy (1999) Prospective cohort 40 Protein/calorie
supplementation
—
Moriarty (1981) RCT 51 Protein/calorie
supplementation
—
Salminen (1988) RCT 24 L. acidophilus probiotic 18–27% incidence of diarrhoea
(Po0.01)
80–90% incidence of diarrhoea
Stryker (1986) RCT 64 Low lactose — —
Valerio (1978) RCT 20 PN — —
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lthat there was a strong bias towards severely malnourished
patients entering the parenteral nutrition arm.
Weight changes
Six papers (Valerio et al, 1978; Foster et al, 1980; Kinsella et al,
1981; Salminen et al, 1988; Macia et al, 1991; Chowdhury et al,
2002) recorded changes in actual body weight during pelvic
radiotherapy and these data have been combined and displayed as
mean weight in kilograms at baseline and completion of radio-
therapy for intervention and control arms. Confidence intervals
have been calculated (Figure 1). The mean weight change in
kilograms between the start and end of pelvic radiotherapy was
recorded in seven papers (Valerio et al, 1978; Brown et al, 1980;
Karlson et al, 1989; Bye et al, 1992; Craighead and Young, 1998;
Capirci and Polico, 2000; Pia de la Maza et al, 2001) (Figure 2).
Anecdotal dietary recommendations
Advice regarding diet during pelvic radiotherapy was commonly
related to restriction of fibre, fat and lactose (National Cancer
Institute, Radiation Oncology Online Journal, and Healthcall-UK).
Less common suggestions included supplementation with a wide
range of micronutrients, coenzymes or amino acids (Bio Concepts-
Cancer Update website). Other recommendations included avoid-
ing spicy foods, carbonated drinks and food or drink consumed at
extremes of temperature. None of these recommendations were
referenced (Table 4).
Complementary nutrition
One double-blind randomised controlled trial was identified
(Martin et al, 2002). It assessed the efficacy of introducing an
enzyme supplement (WOBE-MUGOS – 100mg papain, 40mg
Table 4 Internet-based information
Source Recommendation Evidence Conclusion
National Cancer Institute
www.cancer.gov
Diet low in lactose, fat and residue
Avoid It explains that the evidence is not clear but
that such a diet can be effective in managing
symptoms
No conclusive evidence
Milk and milk products
Whole bran/cereal, nuts and seeds
Fried/fatty foods
Fresh fruit, raw veg
Strong spices/herbs
Choc, tea, coffee, caffeinated soft drinks, alcohol
Ingest foods at room temp
Drink 3l fluid, let carbonated drinks lose their fizz
Add nutmeg to decrease gut motility
Start low-residue diet on day 1 RT
Radiation Oncology
Online Journal, USA
www.rooj.com
Low residue diet
Increased fluid intake No references It is clear why some but not
all of the recommendations
are made
Small, frequent meals
Reduce alcohol
Avoid
High roughage foods and raw veg
Tobacco (stimulates gut)
Food of extreme temps
Carbonated drinks-cause gas
Include high potassium foods
Add nutmeg
HealthCall-UK www.internethealthlibrary.com Reduced fat diet Website refers to papers
discussed above
No evidence to make
these
recommendations
Live yogurt and fermented milk products
Bio Concepts-Cancer
Update
www.orthoplex.com.au
Vitamin supplementation before commencing treatment to
prevent toxicity, including C,E, glutamine, b-carotene,
adenosine, cysteine and quercetin
No references included on this web page Some of the suggestions
have been investigated in
clinical studies
Anti-inflammatory agents during treatment, that is, DHA/
EPA, quercetin, adenosine, bromelain, Vitamins E and C
No recommended doses or methods of
administration given
However, no conclusive
evidence is available
Diet supplementation with glutamine, essential fatty acids
and probiotics to prevent radiotherapy-induced diarrhoea
Supplementing with Coenzyme Q10, acetyl-L-carnitine,
lipoic acid and a-ketoglutarate to improve mitochondrial
function and thus energy
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lchymotrypsin and 40mg trypsin) available in Germany. Three
capsules were taken four times each day. On a diarrhoea scale of
0–3(0to46 bowel movements per day), 43% of the intervention
and 64% of the control group experienced only mild symptoms
during pelvic radiotherapy. In all, 57% of the intervention and 36%
of the control group were rated as having moderate or severe
bowel symptoms (P¼0.11). The Bristol Cancer Help Centre
website provided some information regarding diet during radio-
therapy. In addition to their controversial restrictive dietary advice
aimed at all patients with cancer, there was specific advice to
reduce fibre while having radiotherapy to the pelvis.
Dietary modifications after pelvic radiotherapy In total, 17
studies examined the use of dietary modification after pelvic
radiotherapy to help to reduce or resolve existing postirradiation
gastrointestinal symptoms (Table 5). The nutritional interventions
included:
  Probiotic supplementation in fermented milk or sachet
presentation compared to placebo (Henriksson et al, 1995;
Urbancsek et al, 2001).
  Elemental diet (uncontrolled) (Beer et al, 1985).
  Low-fat diet (uncontrolled) or low fat with bile acid sequestrant
(Bosaeus et al, 1979; Danielsson et al, 1991).
  Gluten and cow’s milk protein free with additional lactose and
reduced fat/residue (Donaldson et al, 1975).
  Parenteral nutrition support (Haddad et al, 1974; Miller et al,
1979; Lavery et al, 1980; Silvain et al, 1992; Scolapio et al, 2002).
  Reduction of high-fibre foods (Sekhon, 2000; Gami et al, 2003).
  Vitamin A, vitamins C and E and magnesium micronutrient
therapy (Cohen and Kitzes, 1985; Kennedy et al, 2001; El Younis
and Abulafia, 2003; Levitsky et al, 2003).
Probiotics were used in two double-blinded randomised studies
(Henriksson et al, 1995; Urbancsek et al, 2001), which included 246
patients. These were supplemented into diet as 300ml twice daily
of a fermented yogurt product containing active L1A Lactobacillus
lactis and one Lactobacillus rhamnosus sachet three times daily,
respectively. Neither study identified significant improvements in
chronic bowel symptoms in patients randomised to the interven-
tion. In one trial (Henriksson et al, 1995), gastrointestinal
symptoms improved in both groups. However, the control group
Table 5 Dietary modifications after pelvic radiotherapy
Study Study type n Intervention
Bowel toxicity
Intervention Control
Beer (1985) Prospective cohort 8 Elemental diet Steatorrhoea in seven out of eight patients before
intervention
Bosaeus (1979) Prospective cohort 9 Low-fat diet —
Cohen (1985) Prospective cohort 20 Magnesium 3 days to stop
diarrhoea
2–6 weeks to stop
diarrhoea
Danielsson
(1991)
Prospective cohort 7 Low-fat diet and bile
acid sequestrant
Moderate improvement in symptoms in all patients
Donaldson
(1975)
Retrospective 5 Gluten, cow’s milk
protein free. Low
lactose, fat and residue
All cases asymptomatic at 1 year
El Younis
(2003)
Prospective cohort
(conference abstract)
9 Vitamin C and E All symptoms subsided at 6–12 weeks
Gami (2003) Qualitative 107 — —
Haddad (1974) Case report 1 Elemental diet Symptoms resolved on ED
Henriksson
(1995)
Double-blind RCT 40 L. Lactis probiotic —
Kennedy
(2001)
Prospective cohort 20 Vitamin C and E Diarrhoea, bleeding and urgency resolved after 4 weeks
Lavery (1980) Prospective cohort 5 PN —
Levitsky (2003) Case report 1 Vitamin A Complete regression of pain and symptoms
Miller (1979) Prospective cohort 10 PN —
Scolapio (2002) Retrospective 54 PN —
Sekhon (2000) Qualitative 48 — —
Silvain (1992) Prospective cohort 31 PN —
Urbancsek
(2001)
Double-blind RCT 206 L. rhamnosus probiotic Reduction (Po0.05) in symptoms in both groups.
P40.05 between groups
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Figure 1 Weight changes and pelvic radiotherapy. (A chart depicting
changes in actual weight from start to end of pelvic radiotherapy. A
comparison between control and intervention groups is shown.)
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lwas taking a placebo probiotic supplement containing strains
thought not to be relevant for gastrointestinal symptoms.
Elemental diet as a complete source of nutrition was investigated
in a crossover study to manage chronic diarrhoea after pelvic
radiotherapy in a group of five malnourished patients from a
cohort with chronic pelvic radiation complications (Beer et al,
1985). A decrease in faecal weight and the absence of abnormal
hydrogen breath tests were reported. Diarrhoeal symptom scores
were not measured. A case report (Haddad et al, 1974) using
exclusive long-term oral elemental diet (27kcalkg
 1day
 1 with 8%
medium chain triglyceride) to treat a patient with abdominal
distension, malabsorption and pain showed complete resolution of
symptoms while the patient consumed this diet.
Low-fat dietary regimens were used in two studies (Bosaeus et al,
1979; Danielsson et al, 1991), which included 187 patients. A
significant reduction in bile salt malabsorption using a
40gfat
 1day
 1 diet in nine patients was reported (Bosaeus et al,
1979). The other study (Danielsson et al, 1991) observed only a
moderate improvement in symptoms with the use of a bile acid
sequestrant in addition to a low-fat diet.
A gluten-free, cow’s milk protein-free, low-residue and low-fat
diet was implemented in children with severe radiation enteritis
following pelvic irradiation (Donaldson et al, 1975). The five case
reports suggested that malabsorption and overall nutritional status
could be improved with this dietary intervention.
Four cohort studies in patients with chronic, intractable bowel
damage after radiotherapy (Miller et al, 1979; Lavery et al, 1980;
Silvain et al, 1992; Scolapio et al, 2002) assessed parenteral
nutrition support in a total of 100 patients. Cyclical nocturnal
parenteral nutrition was unsuccessful in controlling severe
radiation enteritis symptoms in 48% of the patients (Silvain et al,
1992). Nutritional status improved in a small cohort (Lavery et al,
1980). Parenteral nutrition was administered for 6–30 months and
once weight had stabilised, a mean increase of 12.9kg was
reported. This is in agreement with a similar cohort study (Miller
et al, 1979), which reported a 60% survival rate at 1 year with a
mean weight gain of 8.7kg ( 2.1 to 15). A retrospective study
indicated that cumulative survival in patients supported by home
parenteral nutrition was 76% at 1 year. There were no comments
regarding whether any of the symptoms attributed to radiation
bowel damage changed over that period.
Relevant qualitative research was also identified (Sekhon, 2000;
Gami et al, 2003). Two studies assessed self-imposed changes to
dietary intake made by patients with bowel discomfort after
radiotherapy. More than 50% of women with chronic bowel change
reported increased stool frequency with consumption of bran,
pulses and nuts. In 107 patients (Gami et al, 2003), no dietary
manipulation gave consistent benefit, except for 14 out of 15
patients who eliminated or reduced intake of uncooked vegetables
from their diet and reported that bowel symptoms had improved.
The use of micronutrient supplementation in patients with
proctitis and other large bowel damage resulting from pelvic
radiotherapy has been reported in three studies (Cohen and Kitzes,
1985; Kennedy et al, 2001; Levitsky et al, 2003) and one conference
abstract (El Younis and Abulafia, 2003) with a combined total of 50
patients. An oral dose of 8000 IU vitamin A twice daily
administered over 7 weeks is described in a case report (Levitsky
et al, 2003). All pain and clinical signs of anal ulceration resolved
after this intervention. Therapeutic doses of vitamin C (500mg
three times daily) and vitamin E (400IU three times daily) in
combination have been used in two studies to treat radiation
proctitis (Kennedy et al, 2001; El Younis and Abulafia, 2003).
Statistically significant improvements in patient-reported symp-
toms of bleeding, diarrhoea and urgency, but not pain, were noted
and of those patients followed to 1 year, symptom regression was
sustained (Kennedy et al, 2001). The other study reported all
symptoms subsiding by 6–12 weeks of treatment (El Younis and
Abulafia, 2003). Finally, a small cohort study described rapid
resolution of diarrhoeal symptoms in patients with hypomagne-
saemia and radiation-induced proctosigmoiditis with intravenous
infusion of magnesium sulphate over 3 days, compared to delayed
response on a low-residue diet and use of antidiarrhoeal
medication (Cohen and Kitzes, 1985).
DISCUSSION
This review suggests that the incidence of malnutrition in patients
about to start pelvic radiotherapy is 11–33%. Up to 83% of
patients lost weight during treatment. Low-fat diets, probiotic
supplementation and elemental diet may be beneficial in prevent-
ing acute gastrointestinal symptoms. The evidence for the use of
nutritional intervention to manage chronic gastrointestinal symp-
toms is limited. The use of low-fat diets, therapeutic doses of
antioxidant vitamins and probiotic supplementation may be
helpful. A reduced intake of raw vegetables and fibrous foods
may also be effective.
While these conclusions are based on rather weak evidence, they
are supported by findings in other disease states. The use of
elemental diets to induce remission in Crohn’s disease is well
established (O’Morain et al, 1984; Saverymuttu et al, 1985; Gorard
et al, 1993). Acute radiation bowel damage is also characterised by
an inflammatory response. The fat composition of an enteral feed
may be important in achieving remission in Crohn’s disease
(Griffiths et al, 1995; Bamba et al, 2003). Enteral feeds containing
higher proportions of medium-chain triglycerides and n-3 long-
chain fatty acids have been reported in studies to infer favourable
outcomes when compared with n-6 long-chain fatty acids. This is
probably due to their role in the production of eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), abundant in fish
oils, which have anti-inflammatory effects as opposed to n-6 fatty
acids, precursors of arachidonic acid, the substrate for inflamma-
tory eicosanoids (Gorard, 2003). Either this mechanism or its role
in reducing the metabolic workload of the gut, or its effects on bile
acid or pancreatic enzyme secretion, may explain why elemental
diet could be helpful during radiotherapy. Further detailed study is
required.
There is also a rationale for the beneficial effect of probiotics in
radiation-induced damage. Pathogenic bacterial colonisation can
increase the severity of radiation-induced diarrhoea (Urbancsek
et al, 2001). Re-colonisation with an optimal species could
attenuate such an effect (Urbancsek et al, 2001). Probiotic bacteria
can also signal with the gastrointestinal epithelium via mucosal
regulatory T-cells to modulate intestinal inflammation (Caradonna
et al, 2000). Lactose intolerance secondary to an inflamed mucosa
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Figure 2 Mean change in weight during pelvic radiotherapy.
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ferment luminal lactose to prevent osmotic diarrhoea from
occurring.
Finally, ionising radiation is a pro-oxidant process and creates
free radicals. Antioxidant vitamins A, C and E may have a
synergistic effect in scavenging reactive oxygen species and play a
beneficial role in the molecular mechanism of ischaemic injury in
the gut (Empey et al, 1992). For these reasons, supplementation
with therapeutic doses to patients with chronic radiation bowel
damage, which is a vascular, non inflammatory process, may
improve clinical symptoms (Thomson et al, 1998).
There is a scientific basis for studies of nutritional intervention
in humans. A large number of animal experiments have identified
potential physiological mechanisms occurring in the small and
large intestine during and after pelvic radiotherapy. Interventional
studies using elemental diet, micronutrient supplementation and
probiotics suggest that some of these physiological mechanisms
can be blocked, leading to significant reduction in radiation
damage (Hugon and Bounous, 1972, 1973; Bounous et al, 1973;
Pageau et al, 1975; Pageau and Bounous, 1977; McArdle et al, 1985,
1986; McArdle, 1994; Wiseman et al, 1996; Mutlu-Turkoglu et al,
2000).
The primary aim of nutritional intervention should be to show
benefit in relevant outcomes using adequate tools to measure
gastrointestinal toxicity. Most published studies have failed to do
this either because of inadequacies in their methodology or
because they fail to report important end points.
There are many key questions that remain to be answered. What
physiological changes occur in the human gastrointestinal tract
when the pelvis is irradiated? How significant are such changes? Can
a specific nutritional intervention given during pelvic radiotherapy
modulate individual physiological changes? Does this prevent the
onset or reduce the severity of clinically occurring gastrointestinal
symptoms? When should nutritional intervention be given? How
should it be given? Which formulations would enable compliance?
Which patients would benefit from intervention?
To begin to answer these questions, well-designed randomised
studies are needed. Health professionals working with these
patients who may not be trained in nutrition will need to
adopt a multidisciplinary approach to research. Patients need to
consent to participate in randomised studies in which they may
not receive the perceived ‘beneficial’ intervention. This is difficult
at a time of high anxiety and uncertainty as a result of their
diagnosis. Finally, appropriate end points using established,
comprehensive, validated assessment techniques must be incor-
porated in studies that are large enough to answer the questions
asked, to ensure that the results obtained are meaningful in
relation to clinical practice.
Gastrointestinal symptoms induced by pelvic radiotherapy can
cause morbidity and distress in the acute phase during treatment
and can also develop into a chronic, intractable form months or
years after the cessation of treatment (Denton et al, 2002).
Increasingly, patients are being treated successfully and curatively
(UKCCCR Anal Cancer Trial Working Party, 1996). However, if life
expectancy is increased then it is even more crucial to ensure that
an individual patient’s quality of life remains high and is not
detrimentally affected by the very treatment that has saved their
life. To conclude, it is imperative that well-designed randomised
controlled studies are carried out to evaluate the nutritional
interventions that have been identified by current literature as
having potential benefit in patients treated with pelvic radio-
therapy.
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